Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Hypersound-Enhanced Intracellular Delivery of Drug-Loaded Mesoporous Silica Nanoparticles in a Non-Endosomal Pathway.

Lu Y, Palanikumar L, Choi ES, Huskens J, Ryu JH, Wang Y, Pang W, Duan X.

ACS Appl Mater Interfaces. 2019 Jun 5;11(22):19734-19742. doi: 10.1021/acsami.9b02447. Epub 2019 May 23.

PMID:
31090387
2.

Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.

Hakeem A, Zahid F, Zhan G, Yi P, Yang H, Gan L, Yang X.

Int J Nanomedicine. 2018 Feb 19;13:1029-1040. doi: 10.2147/IJN.S146955. eCollection 2018.

3.

Mesoporous silica nanorods for improved oral drug absorption.

Zheng N, Li J, Xu C, Xu L, Li S, Xu L.

Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1132-1140. doi: 10.1080/21691401.2017.1362414. Epub 2017 Aug 8.

PMID:
28783976
4.

Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.

Wei Y, Gao L, Wang L, Shi L, Wei E, Zhou B, Zhou L, Ge B.

Drug Deliv. 2017 Nov;24(1):681-691. doi: 10.1080/10717544.2017.1309475.

PMID:
28414557
5.

Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.

Cheng YJ, Luo GF, Zhu JY, Xu XD, Zeng X, Cheng DB, Li YM, Wu Y, Zhang XZ, Zhuo RX, He F.

ACS Appl Mater Interfaces. 2015 May 6;7(17):9078-87. doi: 10.1021/acsami.5b00752. Epub 2015 Apr 24.

PMID:
25893819
6.

Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.

Feng W, Nie W, He C, Zhou X, Chen L, Qiu K, Wang W, Yin Z.

ACS Appl Mater Interfaces. 2014 Jun 11;6(11):8447-60. doi: 10.1021/am501337s. Epub 2014 Apr 30.

PMID:
24745551
7.

GQDs-MSNs nanocomposite nanoparticles for simultaneous intracellular drug delivery and fluorescent imaging.

Flak D, Przysiecka Ł, Nowaczyk G, Scheibe B, Kościński M, Jesionowski T, Jurga S.

J Nanopart Res. 2018;20(11):306. doi: 10.1007/s11051-018-4416-y. Epub 2018 Nov 17.

8.

Global gene expression analysis of cellular death mechanisms induced by mesoporous silica nanoparticle-based drug delivery system.

Li X, He Q, Shi J.

ACS Nano. 2014 Feb 25;8(2):1309-20. doi: 10.1021/nn4046985. Epub 2014 Jan 13.

PMID:
24392791
9.

TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.

Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H.

Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:108-117. doi: 10.1016/j.msec.2017.11.040. Epub 2017 Nov 28.

PMID:
29519418
11.

Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.

Kwon S, Singh RK, Kim TH, Patel KD, Kim JJ, Chrzanowski W, Kim HW.

Acta Biomater. 2014 Mar;10(3):1431-42. doi: 10.1016/j.actbio.2013.10.028. Epub 2013 Nov 15.

PMID:
24239681
12.

Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.

Cheng YJ, Zhang AQ, Hu JJ, He F, Zeng X, Zhang XZ.

ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2093-2103. doi: 10.1021/acsami.6b12647. Epub 2017 Jan 12.

PMID:
28032742
13.

Mesoporous silica nanoparticles for 19F magnetic resonance imaging, fluorescence imaging, and drug delivery.

Nakamura T, Sugihara F, Matsushita H, Yoshioka Y, Mizukami S, Kikuchi K.

Chem Sci. 2015 Mar 1;6(3):1986-1990. doi: 10.1039/c4sc03549f. Epub 2014 Dec 23.

14.

Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.

Zhang J, Sun Y, Tian B, Li K, Wang L, Liang Y, Han J.

Colloids Surf B Biointerfaces. 2016 Aug 1;144:293-302. doi: 10.1016/j.colsurfb.2016.04.015. Epub 2016 Apr 8.

PMID:
27107383
15.

Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.

Tambe P, Kumar P, Paknikar KM, Gajbhiye V.

Int J Nanomedicine. 2018 Nov 19;13:7669-7680. doi: 10.2147/IJN.S184634. eCollection 2018.

16.

Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.

Sun JH, Zhang W, Zhang DY, Shen J, Tan CP, Ji LN, Mao ZW.

J Biomater Appl. 2018 Apr;32(9):1253-1264. doi: 10.1177/0885328218758925. Epub 2018 Feb 15.

PMID:
29448866
17.

A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.

Zhang Q, Zhao H, Li D, Liu L, Du S.

Colloids Surf B Biointerfaces. 2017 Jan 1;149:138-145. doi: 10.1016/j.colsurfb.2016.10.018. Epub 2016 Oct 11.

PMID:
27750088
18.

Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release.

Li QL, Sun Y, Sun YL, Wen J, Zhou Y, Bing QM, Isaacs LD, Jin Y, Gao H, Yang YW.

Chem Mater. 2014 Nov 25;26(22):6418-6431. Epub 2014 Oct 20.

19.

EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.

Xie X, Li F, Zhang H, Lu Y, Lian S, Lin H, Gao Y, Jia L.

Eur J Pharm Sci. 2016 Feb 15;83:28-35. doi: 10.1016/j.ejps.2015.12.014. Epub 2015 Dec 9.

PMID:
26690044
20.

Engineering Polyzwitterion and Polydopamine Decorated Doxorubicin-Loaded Mesoporous Silica Nanoparticles as a pH-Sensitive Drug Delivery.

Ji F, Sun H, Qin Z, Zhang E, Cui J, Wang J, Li S, Yao F.

Polymers (Basel). 2018 Mar 15;10(3). pii: E326. doi: 10.3390/polym10030326.

Supplemental Content

Support Center